A former Ohio State University (OSU) nurse anesthetist was sentenced this week to 2 years in prison for theft and other charges related to a cancer hoax that she perpetrated.
All news from Forensic Medicine & Toxicology
The National Toxicology Program (NTP) concluded there is clear evidence that male rats exposed to high levels of radio frequency radiation (RFR) like that used in 2G and 3G cell phones developed cancerous heart tumors, according to final reports released today.
Women between the ages of 30 and 39 who have at least 1 of 3 breast cancer risk factors may benefit from starting their annual mammography screening at age 30, according to results from a large-scale study that was presented at the 2018 Radiological Society of North America Annual Meeting.
A more comfortable and reliable blood-sugar monitoring system is being designed by researchers in Sweden for people with diabetes. After successfully testing a prototype of a microneedle patch on a human subject, the completion of a system for clinical tests is now underway.
Portola Pharmaceuticals announced that the FDA approved its Prior Approval Supplement for the second generation of andexanet alfa, allowing for its broad commercial launch in the U.S.
Researchers have found a stem cell enzyme copy edits more than 20 tumor types, providing a new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
The FDA expanded the approval of dasatinib tablets to include its use with chemotherapy for children aged 1 year or older with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Few people are familiar with the term "step therapy," but most Americans have health insurance policies that adopt it. Step therapy programs, also known as "fail first policies," require patients to try less expensive treatments before insurers agree to pay for more costly alternatives.
Thyroid cancer is the most rapidly increasing cancer diagnosis in the United States. While surgeries to remove all or part of the thyroid are the most common treatment, there has been a debate about the risks to the patient, how common those risks are, and how to prevent them.